Back
Alnylam Pharmaceuticals Stock Price Chart
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
23
ALNY
Alnylam Pharmaceuticals
Last Price:
248.48
Seasonality Move:
10.85%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 252.75 | Sell |
| 20-day SMA: | 267.61 | Sell |
| 50-day SMA: | 273.13 | Sell |
| 200-day SMA: | 210.87 | Buy |
| 8-day EMA: | 250.09 | Sell |
| 20-day EMA: | 262.36 | Sell |
| 50-day EMA: | 266.92 | Sell |
| 200-day EMA: | 230.73 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.64 | Sell |
| Relative Strength Index (14 RSI): | 39.68 | Sell |
| Chaikin Money Flow: | 997085 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (254.01 - 292.55) | Sell |
| Bollinger Bands (100): | (248.69 - 281.73) | Sell |
Alnylam Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 248.79 while ALNY 8-day simple moving average is 252.75, which is a Sell signal.
- The stock price of ALNY is 248.79 while Alnylam Pharmaceuticals 20-day SMA is 267.61, which makes it a Sell.
- Alnylam Pharmaceuticals 50-day simple moving average is 273.13 while ALNY share price is 248.79, making it a Sell technically.
- ALNY stock price is 248.79 and Alnylam Pharmaceuticals 200-day simple moving average is 210.87, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
23
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a Sell
The current Alnylam Pharmaceuticals [ALNY] share price is $248.79. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
32.09B
Price in USD:
248.79
Share Volume:
1.04M
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
141.98
Sell
23
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?
The Alnylam Pharmaceuticals stock price is 248.79 USD today. -
Will ALNY stock go up or go down?
Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Alnylam Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 248.79 while ALNY 8-day exponential moving average is 250.09, which is a Sell signal.
- The stock price of ALNY is 248.79 while Alnylam Pharmaceuticals 20-day EMA is 262.36, which makes it a Sell.
- Alnylam Pharmaceuticals 50-day exponential moving average is 266.92 while ALNY share price is 248.79, making it a Sell technically.
- ALNY stock price is 248.79 and Alnylam Pharmaceuticals 200-day simple moving average is 230.73, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
- ALNY Moving Average Covergence Divergence (MACD) indicator is -9.64, suggesting Alnylam Pharmaceuticals is a Sell
- Alnylam Pharmaceuticals Relative Strength Index (RSI) is 39.68, which suggest Alnylam Pharmaceuticals is oversold
- The Bollinger Bands (25) for Alnylam Pharmaceuticals is (254.01 - 292.55), which suggest Alnylam Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Alnylam Pharmaceuticals is (248.69 - 281.73), which suggest Alnylam Pharmaceuticals is a Sell
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.